Dasatinib is a potent ATP-competitive BCR-ABL/SRC inhibitor. It blocks MAPK signaling by binding ATP sites, inducing apoptosis.
Dasatinib (BMS-354825) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Dasatinib (BMS-354825) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.